image
Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.3
-2.96 %
$ 334 M
Market Cap
-4.37
P/E
CASH FLOW STATEMENT
54.9 M OPERATING CASH FLOW
429.85%
17.8 M INVESTING CASH FLOW
171.58%
-49.4 M FINANCING CASH FLOW
-14.58%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis SNDL Inc.
image
50m50m00(50m)(50m)(100m)(100m)(150m)(150m)(200m)(200m)(250m)(250m)(300m)(300m)2018201820192019202020202021202120222022202320232024202420252025
Net Income -96.2 M
Depreciation & Amortization 56.7 M
Capital Expenditures -11 M
Stock-Based Compensation 20 M
Change in Working Capital -7.45 M
Others 83.8 M
Free Cash Flow 43.9 M

Cash Flow

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Feb-2018 Feb-2017
OPERATING CASH FLOW
Net Income (96.2) (176.6) (372.4) (230.2) (206.3) (271.6) (13.0) (1.5)
Depreciation & Amortization 56.7 64.9 47.3 9.6 11.6 9.8 0.4 0.1
Deferred Income Tax (9.4) 0 (7.3) (2.3) 83.1 (4.6) 2.2 0
Stock Based Compensation 20.0 15.4 9.7 12.3 8.6 39.5 4.6 0
Other Operating Activities 91.2 112.4 338.1 56.6 50.9 161.6 (0.4) 0.2
Change in Working Capital (7.4) (32.9) (22.1) (1.5) (5.3) (47.4) 0.9 (0.2)
Cash From Operations 54.9 (16.6) (6.7) (155.4) (57.5) (112.7) (5.2) (1.4)
INVESTING CASH FLOW
Capital Expenditures (11.0) (7.9) (10.9) (3.8) (3.2) (138.1) (7.6) (4.8)
Other Items 28.8 (16.9) (219.3) (492.5) (67.7) (75.0) (2.1) 0.9
Cash From Investing Activities 17.8 (24.8) (230.2) (496.3) (70.9) (213.1) (9.7) (3.9)
FINANCING CASH FLOW
Common Stock Repurchased (13.3) (1.5) (13.4) 0 0 0 0 0
Total Debt Repaid (37.0) (41.0) (37.7) (10.4) (66.8) 185.1 0 6.9
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 0.9 (0.5) 9.3 97.7 27.7 (4.0) 18.9 (7.7)
Cash From Financing Activities (49.4) (43.1) (41.8) 1 149.6 142.7 358.3 18.9 8.7
CHANGE IN CASH
Net Change In Cash 23.3 (84.5) (278.7) 497.9 15.0 31.2 4.0 3.4
FREE CASH FLOW
Free Cash Flow 43.9 (24.6) (17.6) (159.2) (60.7) (250.9) (12.8) (6.2)